tiprankstipranks
Astellas Pharma Inc (ALPMF)
OTHER OTC:ALPMF
US Market
ALPMF
Astellas Pharma
RESEARCH TOOLSreports
Want to see ALPMF full AI Analyst Report?

Astellas Pharma (ALPMF) Income Statement

56 Followers

Astellas Pharma Income Statement

Last quarter (Q2 2026), Astellas Pharma's total revenue was ¥524.32B, an increase of 1.34% from the same quarter last year. In Q2, Astellas Pharma's net income was ¥79.21B. See Astellas Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 26Mar 25Mar 24Mar 23
Total Revenue
¥ 1.91T¥ 2.14T¥ 1.60T¥ 1.52T¥ 1.30T
Gross Profit
¥ 1.56T¥ 1.59T¥ 1.31T¥ 1.23T¥ 1.04T
Operating Expenses
¥ 1.31T¥ 1.18T¥ 1.13T¥ 944.84B¥ 823.13B
Depreciation and Amortization
¥ 199.13B¥ 194.59B¥ 157.84B¥ 105.74B¥ 79.68B
EBITDA
¥ 462.67B¥ 614.29B¥ 282.45B¥ 337.39B¥ 297.83B
Operating Income
¥ 255.67B¥ 419.70B¥ 178.07B¥ 285.43B¥ 220.02B
Other Income/Expenses
¥ -224.44B¥ -43.11B¥ -153.10B¥ -153.07B¥ -63.13B
Pretax Income
¥ 31.24B¥ 376.59B¥ 24.97B¥ 132.36B¥ 156.89B
Net Income
¥ 50.75B¥ 291.54B¥ 17.05B¥ 98.71B¥ 124.09B
Per Share Metrics
Basic EPS
¥ 28.35¥ 162.77¥ 9.50¥ 54.24¥ 67.08
Diluted EPS
¥ 28.24¥ 162.22¥ 9.47¥ 54.09¥ 67.05
Weighted Average Shares Outstanding
 1.79B 1.79B 1.79B 1.82B 1.85B
Weighted Average Shares Outstanding (Diluted)
 1.80B 1.80B 1.80B 1.83B 1.85B
Currency in JPY

Astellas Pharma Earnings and Revenue History